RNDr. Petr Chlapek, DiS., Ph.D.
odborný asistent – Oddělení genetiky a molekulární biologie
kancelář: bud. C13/316
Kamenice 753/5
625 00 Brno
telefon: | 549 49 3970 |
---|---|
e‑mail: |
Počet publikací: 46
2022
-
Serotonin limits generation of chromaffin cells during adrenal organ development
Nature Communications, rok: 2022, ročník: 13, vydání: 1, DOI
-
Thiosemicarbazones and selected tyrosine kinase inhibitors synergize in pediatric solid tumors: NDRG1 upregulation and impaired prosurvival signaling in neuroblastoma cells
Frontiers in Pharmacology, rok: 2022, ročník: 13, vydání: September, DOI
-
Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors
International Journal of Molecular Sciences, rok: 2022, ročník: 23, vydání: 15, DOI
2021
-
A selective p53 activator and anticancer agent to improve colorectal cancer therapy
Cell Reports, rok: 2021, ročník: 35, vydání: 2, DOI
2020
-
Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms
Cancers, rok: 2020, ročník: 12, vydání: 12, DOI
-
Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration
International Journal of Molecular Sciences, rok: 2020, ročník: 21, vydání: 9, DOI
2019
-
Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy
Frontiers in Oncology, rok: 2019, ročník: 9, vydání: NOV 15, DOI
-
New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma
Cancer Letters, rok: 2019, ročník: 446, vydání: 4, DOI
-
Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers
PLOS ONE, rok: 2019, ročník: 14, vydání: 6, DOI
2018
-
Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy
BMC Cancer, rok: 2018, ročník: 18, vydání: 1059, DOI